Improvement of the Oral Bioavailability of Naltrexone in Dogs: A Prodrug Approach

Add time:08/08/2019    Source:sciencedirect.com

In an effort to improve the oral bioavailability of naltrexone [17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one;1], a number of prodrug esters on the 3-hydroxyl group were prepared: the anthranilate (2), acetylsalicylate (3), benzoate (4), and pivalate (5). The oral bioavailability of these prodrugs was determined in dogs. Compounds 2 and 3 exhibited the greatest enhancement of naltrexone bioavailability (45 and 28 times greater than 1, respectively). No correlation was found between the rates of plasma hydrolysis and bioavailability. Naltrexone-3-acetylsalicylate hydrolyzed in human and dog plasma with a fast deacetylation step to naltrexone salicylate followed by a slower hydrolysis step to naltrexone.

We also recommend Trading Suppliers and Manufacturers of naltrexone-3-salicylate (cas 110189-11-2). Pls Click Website Link as below: cas 110189-11-2 suppliers

Prev:Theoretical study on the electronic structures and intramolecular charge transfer of naamine A, naamidine A (cas 110189-06-5) and naamidine G
Next:Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats)